ACE2 and COVID-19: The increased vulnerability of patients with type 2 diabetes to COVID-19 may arise from several factors: there is an upregulation of ACE-2 and furin expression in these individuals, potentially easing the virus's entry into cells; additionally, their T-cell function is often compromised, possibly leading to further dysregulation of the immune system.